Dianthus Therapeutics, Inc. (DNTH) Ownership

$44.73

$0.76 (1.73%)
Last update: 02:32 PM EST
Day's range
$43.28
Day's range
$45.46

Dianthus Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 11/13/2025 5.97 M $234.94 M   31.39% 16.67%
FAIRMOUNT FUNDS MANAGEMENT LLC 11/14/2025 3.31 M $130.14 M   22.16% 9.23%
AVIDITY PARTNERS MANAGEMENT LP 11/14/2025 3.20 M $126.08 M   83.84% 8.94%
RA CAPITAL MANAGEMENT, L.P. 11/14/2025 2.87 M $112.81 M   0.00% 8.00%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2025 2.58 M $101.43 M   3,366.88% 7.20%
OCTAGON CAPITAL ADVISORS LP 11/14/2025 2.42 M $95.10 M   3.20% 6.75%
POINT72 ASSET MANAGEMENT, L.P. 11/14/2025 2.04 M $80.35 M   46.64% 5.70%
TCG CROSSOVER MANAGEMENT, LLC 11/17/2025 1.68 M $65.98 M   11.65% 4.68%
VANGUARD GROUP INC 11/07/2025 1.64 M $64.62 M   13.56% 4.58%
BLACKROCK, INC. 11/12/2025 1.34 M $52.73 M   -1.38% 3.74%
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC 11/14/2025 1.32 M $51.78 M   -46.99% 3.67%
VESTAL POINT CAPITAL, LP 11/14/2025 1.18 M $46.43 M   -63.13% 3.29%
CITADEL ADVISORS LLC 11/14/2025 1.01 M $39.88 M   52.40% 2.83%
VR ADVISER, LLC 11/14/2025 960.80 K $37.81 M   -3.92% 2.68%
ALLIANCEBERNSTEIN L.P. 11/14/2025 852.38 K $33.54 M   -27.45% 2.38%
BRAIDWELL LP 11/14/2025 835.06 K $32.86 M   100.00% 2.33%
BAKER BROS. ADVISORS LP 11/14/2025 789.76 K $31.08 M   0.00% 2.20%
POLAR CAPITAL HOLDINGS PLC 11/14/2025 748.00 K $29.43 M   100.00% 2.09%
SILVERARC CAPITAL MANAGEMENT, LLC 11/12/2025 674.97 K $26.56 M   604.51% 1.88%
STATE STREET CORP 11/14/2025 671.05 K $26.41 M   -18.18% 1.87%
CATALIO CAPITAL MANAGEMENT, LP 11/14/2025 667.62 K $26.27 M   -10.57% 1.86%
SIO CAPITAL MANAGEMENT, LLC 11/13/2025 577.75 K $22.73 M   144.74% 1.61%
MARSHALL WACE, LLP 11/13/2025 572.94 K $22.55 M   100.00% 1.60%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 536.42 K $21.11 M   10.62% 1.50%
FRANKLIN RESOURCES INC 11/13/2025 450.31 K $17.72 M   100.00% 1.26%
BALYASNY ASSET MANAGEMENT L.P. 11/14/2025 443.70 K $17.46 M   100.00% 1.24%
NANTAHALA CAPITAL MANAGEMENT, LLC 11/14/2025 375.00 K $14.76 M   100.00% 1.05%
5AM VENTURE MANAGEMENT, LLC 11/14/2025 365.05 K $14.36 M   -62.93% 1.02%
VIVO CAPITAL, LLC 11/14/2025 354.00 K $13.93 M   100.00% 0.99%
IKARIAN CAPITAL, LLC 11/14/2025 346.00 K $13.62 M   100.00% 0.97%
CANDRIAM S.C.A. 11/06/2025 301.43 K $11.86 M   25.29% 0.84%
GREAT POINT PARTNERS LLC 11/14/2025 265.80 K $10.46 M   100.00% 0.74%
TANG CAPITAL MANAGEMENT LLC 11/14/2025 264.69 K $10.42 M   0.00% 0.74%
AFFINITY ASSET ADVISORS, LLC 11/13/2025 262.10 K $10.31 M   100.00% 0.73%
GOLDMAN SACHS GROUP INC 11/14/2025 218.77 K $8.61 M   -40.00% 0.61%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2025 216.14 K $8.51 M   1,921.46% 0.60%
ALPHABET INC. 11/07/2025 208.70 K $8.21 M   0.00% 0.58%
BARCLAYS PLC 11/12/2025 204.37 K $8.04 M   215.28% 0.57%
LOGOS GLOBAL MANAGEMENT LP 11/14/2025 200.00 K $7.87 M   100.00% 0.56%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 193.06 K $7.60 M   17.49% 0.54%
TRI LOCUM PARTNERS LP 11/14/2025 182.87 K $7.20 M   100.00% 0.51%
BANK OF AMERICA CORP /DE/ 11/14/2025 180.03 K $7.08 M   9.02% 0.50%
RHENMAN & PARTNERS ASSET MANAGEMENT AB 11/13/2025 173.63 K $6.83 M   37.12% 0.48%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 173.20 K $6.82 M   573.93% 0.48%
NORTHERN TRUST CORP 11/14/2025 157.53 K $6.20 M   -1.74% 0.44%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 11/14/2025 150.00 K $5.90 M   100.00% 0.42%
MILLENNIUM MANAGEMENT LLC 11/14/2025 146.17 K $5.75 M   -25.18% 0.41%
JANE STREET GROUP, LLC 11/14/2025 142.30 K $5.60 M   100.00% 0.40%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 142.20 K $5.60 M   355.77% 0.40%
WALLEYE CAPITAL LLC 11/14/2025 141.13 K $5.55 M   440.04% 0.39%

Dianthus Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 158 institutional investors and hedge funds held shares of Dianthus Therapeutics, Inc.. The most heavily invested institutionals were:

FMR LLC: 5.97 M

Fairmount Funds Management LLC: 3.31 M

Avidity Partners Management LP: 3.2 M

RA CAPITAL MANAGEMENT, L.P.: 2.87 M

WELLINGTON MANAGEMENT GROUP LLP: 2.58 M

Octagon Capital Advisors LP: 2.42 M

130.74% of Dianthus Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 48.50 M shares in the last 24 months. This purchase volume represents approximately $2.16 B in transactions.